A Safer Way to Treat Irregular Heartbeat: What You Need to Know About AFib's New Treatment

A revolutionary treatment for atrial fibrillation (AFib) is changing how doctors approach one of the most common heart rhythm disorders. Pulsed field ablation (PFA) delivers precisely controlled electric fields to treat AFib with significantly reduced risks and faster procedure times compared to traditional methods.

What Makes This Treatment Different?

Unlike conventional ablation techniques that use heat or freezing temperatures, pulsed field ablation works through electroporation—delivering rapid, high-voltage pulsed electrical fields to heart tissue. "Think of it as a discharge of static electricity—it packs a punch without generating much heat," says Kevin Kwaku, MD, PhD, Director of Cardiac Electrophysiology at Dartmouth Hitchcock Medical Center's Heart and Vascular Center.

This approach offers several key advantages over traditional radiofrequency ablation (which uses heat) and cryoballoon ablation (which uses freezing energy). Clinical trials at Northwestern Medicine found that patients who received PFA experienced excellent outcomes with fewer major complications and significantly faster procedure times.

Why Does AFib Treatment Matter Now?

The timing couldn't be more critical. Atrial fibrillation affects up to 5 million people in the United States, with numbers expected to reach 12.1 million by 2030. AFib is characterized by fast and irregular heartbeats from the heart's upper chambers, and it significantly increases the risk of stroke, blood clots, and other serious complications.

"Some patients describe that it can feel like a fish flopping or a butterfly flapping its wings in your heart," explains Rajbir Sangha, MD, from Dartmouth Hitchcock Medical Center's Heart and Vascular Center. "But not always. Sometimes people don't feel atrial fibrillation happening at all, or have more subtle symptoms such as fatigue or shortness of breath."

Several factors can increase your risk of developing AFib:

• High Blood Pressure: The most common modifiable risk factor for heart rhythm disorders
• Excess Weight: Carrying extra pounds puts additional strain on the heart's electrical system
• Sleep Apnea: Disrupted breathing patterns during sleep can trigger irregular heartbeats
• Alcohol Consumption: Drinking alcohol can increase AFib episodes
• Family History: Genetic factors play a role in heart rhythm disorders
• Chronic Conditions: Including hyperthyroidism, diabetes, and asthma

How Effective Is the New Treatment?

Studies show that around 70 to 80 percent of patients experience significant reduction in atrial fibrillation and its symptoms after a single ablation procedure. The Food and Drug Administration (FDA) approved PFA after Northwestern Medicine participated in two clinical trials that demonstrated the procedure's safety and effectiveness.

"Pulsed field ablation represents a significant advancement in the field of electrophysiology," says Bradley P. Knight, MD, director of Cardiac Electrophysiology at Northwestern Medicine. "PFA has the potential to be a real-game changer for our patients and the way we treat AFib."

The procedure involves inserting a flexible catheter into a blood vessel and feeding it into the heart, where the pulsed electrical fields target the area around the pulmonary veins entering the left atrium. This results in a lower risk of damage to surrounding non-cardiac structures compared to thermal ablation methods.

While not everyone with AFib needs ablation, the procedure is typically considered when medications cannot adequately manage heart rhythm. "To have the best chance of maintaining normal rhythm, it is critical for patients to work on managing their modifiable risk factors," emphasizes Dr. Kwaku.